BRIEF-IntelGenx Receives Health Canada Clearance To Begin Phase 2a Study With Montelukast Versafilm
December 15, 2017 at 08:11 AM EST
* INTELGENX RECEIVES HEALTH CANADA CLEARANCE TO BEGIN PHASE 2A STUDY WITH MONTELUKAST VERSAFILM(TM) IN MILD TO MODERATE ALZHEIMER'S DISEASE